Rapporto sull’analisi delle dimensioni del mercato e delle quote della tosse cronica | Previsioni 2031

  • Report Code : TIPRE00011584
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 180
Buy Now

Si prevede che il mercato della tosse cronica raggiungerà i 9.854,8 milioni di dollari entro il 2027 rispetto ai 5.430,0 milioni di dollari del 2019; si stima che crescerà a un CAGR del 7,8% dal 2020 al 2027.

La tosse cronica è definita come una tosse persistente che dura fino a 6-8 settimane. Influisce in modo significativo sulla vita dei pazienti interrompendo il sonno, creando sensazione di vomito, vertigini e persino fratture costali. È causato da molteplici motivi come infezioni, asma e malattia da reflusso gastroesofageo (GERD). La crescita del mercato della tosse cronica è attribuita a fattori quali l’aumento dell’incidenza della tosse cronica e si prevede che i crescenti sviluppi di prodotti per il trattamento della tosse cronica guideranno la crescita del mercato. Tuttavia, i richiami dei prodotti rappresentano il principale fattore che ostacola la crescita del mercato.

Mercati regionali redditizi per la tosse cronica

MarketInsights

Aumento dell'incidenza della tosse cronica

La tosse cronica è causata dall'asma, dal reflusso acido dallo stomaco e dal gocciolamento retronasale. Anche condizioni come infezioni, bronchiti e malattie polmonari possono portare a tosse cronica. Condizioni come l'asma sono in aumento in tutto il mondo; è comunemente visto tra bambini e adulti. È una delle principali cause del crescente carico sanitario negli Stati Uniti. Ad esempio, secondo i dati dei Centri per il controllo e la prevenzione delle malattie (CDC) pubblicati nel 2019, una persona su tre soffre di asma negli Stati Uniti. In tutta l'America, oltre 25 milioni di persone convivono con l'asma, che rappresenta circa l'8% negli adulti e quasi l'8,5% nei bambini.

Nelle regioni in via di sviluppo come l'Asia del Pacifico e In Medio Oriente e in Africa la prevalenza delle malattie croniche è in aumento a causa dell’inquinamento e delle infezioni. I paesi di queste regioni sono altamente popolati. Sebbene la tosse sia una malattia non trasmissibile, è in aumento in modo significativo nei paesi. Diversi governi si stanno adoperando per controllare l’incidenza della tosse cronica nei rispettivi paesi. Secondo la National Health Policy 2017, l'India, la mortalità prematura dovuta a malattie non trasmissibili, compresa la tosse cronica, sarà ridotta di circa il 25% entro il 2025.

Nel Mezzo Est e Africa, le malattie respiratorie sono in aumento a causa delle condizioni climatiche. I paesi circondati dai dolci sono soggetti al rischio di malattie respiratorie a causa della facile diffusione degli allergeni. A oltre il 60-70% dei pazienti nei paesi vengono diagnosticate malattie respiratorie. Un'altra delle principali cause di tosse cronica tra le persone della regione è il fumo. Quasi il 30% delle persone è dipendente dal fumo, il che porta ulteriormente a un aumento dell'incidenza di tosse cronica.

Approfondimenti sulle classi di farmaci

< p> In base alla classe di farmaci, il mercato della tosse cronica è segmentato in antistaminici, contorsionisti, decongestionanti, farmaci combinati, antibiotici, bloccanti dell'acido e altre classi di farmaci. Il segmento dei farmaci combinati ha detenuto la quota maggiore del mercato nel 2019 e si stima che lo stesso segmento riporterà il CAGR più elevato del mercato durante il periodo di previsione. Si stima che la crescita del segmento sia dovuta ai vantaggi offerti dalla combinazione di farmaci, poiché l'uso di farmaci combinati può trattare più di un sintomo. Inoltre, la combinazione di farmaci è ampiamente disponibile come farmaci da banco.

Mercato globale della tosse cronica, per classe di farmaco - 2019 e 2027

Percorso di approfondimenti amministrativi

In base alla via di somministrazione, il mercato della tosse cronica è segmentato in via orale, iniezioni, inalazione e altre vie di somministrazione. Il segmento orale ha detenuto la quota maggiore del mercato nel 2019. Tuttavia, si stima che il segmento inalatorio registrerà il CAGR più elevato sul mercato durante il periodo di previsione.

Approfondimenti sul canale di distribuzione

In base al canale di distribuzione, il mercato della tosse cronica è segmentato in farmacia ospedaliera, farmacia online e farmacia al dettaglio. Il segmento delle farmacie ospedaliere ha detenuto la quota maggiore del mercato nel 2019. Tuttavia, si stima che il segmento delle farmacie online registrerà il CAGR più elevato sul mercato durante il periodo di previsione.

< h3>Approfondimenti strategici

Le strategie inorganiche sono le strategie più comunemente adottate dalle aziende nel mercato della tosse cronica, che consente loro di espandere la propria presenza globale e i portafogli di prodotti e servizi. Gli operatori del mercato hanno anche adottato strategie organiche come la strategia di lancio di prodotti per ampliare la propria base di clienti globale, che consente loro anche di mantenere il proprio marchio a livello globale.

Mercato globale della tosse cronica &ndash ; Per classe di farmaco

  • Antistaminici
  • Corticosteroidi
  • Decongestionanti
  • Farmaci combinati
  • Antibiotici
  • Antiacido
  • Altra classe di farmaci

Mercato globale della tosse cronica– Per via di somministrazione

  • Iniezioni
  • Orale
  • Nasale
  • Altra via di somministrazione

Mercato globale della tosse cronica– Per canale di distribuzione

  • Farmacia ospedaliera
  • Farmacia online
  • Farmacia al dettaglio

Cronaca < /em>Mercato della tosse– Per area geografica

  • Nord America

    • Stati Uniti
    • Canada
    • Messico
  • Europa
    • Francia
    • Germania
    • Italia
    • Regno Unito
    • Spagna
  • Asia Pacifico (APAC)
    • Cina
    • India
    • Corea del Sud
    • Giappone
    • Australia
  • Medio Oriente e Africa (MEA)
    • Sudafrica
    • Arabia Saudita
    • Emirati Arabi Uniti
  • America centrale e meridionale
    • Brasile
    • Argentina
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is chronic cough?

Chronic cough is defined as a persistent cough that lasts long up to 6-8 weeks. It significantly affects the life of the patients by interrupt sleeping, vomiting, light-headedness, and even rib fractures. It is caused due to multiple reasons such as infections, asthma, gastro esophageal reflux disease (GERD), among others.

What are the driving factors for the chronic cough market across the globe?

The growth of market is likely to grow due to factors such as rising incidences of chronic cough and growing product developments to treat chronic cough are expected to drive the growth of the market. However, product recall is the major factor hindering the market growth.

What is the average cost of chronic cough medicines?

The cost of chronic cough medicine starts from US$ 2 and above. The price of medicine depends upon the type of drug, whether it is tablet, syrup, or nasal spray. The generic and OTC drugs are much cheaper compared to the branded and prescribed ones.

The List of Companies - Chronic Cough Market

  1. Novartis AG
  2. Teva Pharmaceutical Industries Ltd
  3. Glaxo Smith Klineplc.
  4. Bayer AG
  5. Mylan N.V.
  6. Amneal Pharmaceuticals, Inc.
  7. Cipla Inc.
  8. Reckitt Benckiser Group plc.
  9. Sun Pharmaceutical Industries Ltd
  10. AurobindoPharma Ltd

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports